Science and Discovery

Obesity Drug

2 articles

A person looking distressed, clutching their stomach, symbolizing the widespread gut issues reported with Eli Lilly's obesity drug.
Cosmos & Space

Eli Lilly Obesity Drug Causes Widespread Gut Issues

Nearly half of the 70,000 GLP-1 drug users surveyed reported at least one side effect.

Marcus Cole·June 26, 2026
Scientist in a lab with a vial of Pfizer's berobenatide, symbolizing a breakthrough in obesity treatment with potential for monthly dosing.
Health & Medicine

Pfizer's obesity drug shows potential for monthly dosing

Mid-stage study data reveals Pfizer's experimental obesity drug, berobenatide, could achieve significant weight loss with a groundbreaking monthly dosing schedule, a stark contrast to current weekly o

Aram Sarkisian·June 7, 2026